Priscilla M. Pastrana

FDA investigator

Appears on 6 documents from 2020 to 2026, most often at sites in Massachusetts. Most often cites production record review (21 CFR 211.192).

6
Documents on file
4.0
Observations per 483
2020
First seen
2026
Most recent

What they cite most

From 22 observations

Activity by year

2020: 1, 2022: 2, 2023: 1, 2024: 1, 2026: 1

Where

Massachusetts 1 · New Hampshire 1 · Pennsylvania 1 · United Kingdom 1

Often inspects with

Bo Liang· Anna Kwilas· Annette Melendez

Is Priscilla M. Pastrana coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Corixa CorporationMar 12, 2026
483 Lonza Houston Inc.Mar 7, 2024 · Portsmouth, New Hampshire
483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCSep 19, 2023 · Andover, Massachusetts
483 Krystal Biotech, Inc.Nov 16, 2022 · Pittsburgh, Pennsylvania
483 Bio Products Laboratory LtdAug 30, 2022 · Elstree, United Kingdom
483 Form 483 · FEI 301543430Jun 19, 2020 · Hannans

About this profile

What does Priscilla M. Pastrana inspect?

Priscilla M. Pastrana appears on 6 documents on file covering 6 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Priscilla M. Pastrana is dated Mar 12, 2026.